Status:

COMPLETED

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

HIV Infections

Eligibility:

All Genders

6-12 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to compare the effects of anti-HIV drug courses of different lengths in infants who became HIV infected at birth.

Detailed Description

In South Africa, an estimated 250,000 infants are born to HIV-infected mothers each year. A high percentage of perinatal HIV infections are due to inadequate or absent mother-to-child transmission pro...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Infants:
  • NOTE: Per Letter of Amendment dated 04/04/07, Part B of this study is no longer recruiting participants. Per Letter of Amendment dated 09/16/08 Arm 1 of this study is longer recruiting.
  • HIV infected
  • Antiretroviral naive. Infants who have previously received antiretroviral drugs used to prevent mother-to-child transmission are eligible for the study.
  • Parent or legal guardian willing to provide informed consent and comply with study requirements
  • Exclusion Criteria for Infants:
  • Any major life-threatening congenital abnormalities
  • Severe CDC Stage B or C disease
  • Liver enzyme, absolute neutrophil count, hemoglobin, electrolyte, creatinine, or clinical toxicity of Grade 3 or higher at screening
  • Any acute or clinically significant medical event that would preclude participation in the study. Randomization can take place as soon as the incurrent illness has resolved if the child is still less than or equal to 12 weeks of age.
  • Use of investigational drugs
  • Require certain medications. More information on this criterion can be found in the protocol.
  • Inability to tolerate oral medication
  • Birth weight less than 2 kg (4.4 lbs)

Exclusion

    Key Trial Info

    Start Date :

    July 1 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2013

    Estimated Enrollment :

    377 Patients enrolled

    Trial Details

    Trial ID

    NCT00102960

    Start Date

    July 1 2005

    End Date

    January 1 2013

    Last Update

    November 2 2021

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.